CME Activity Information	Important dates for this Course
Accreditation/CME Credit CME Instructions For Credit Disclosure Privacy Statement Hardware/Software Requirements	Released: September 1, 2004 Expired: September 1, 2005

OBJECTIVES After reading the article, What Is New in Lymphoma?, the learner should be able to:

•  Discuss the treatment strategies now under study for follicular non-Hodgkin lymphoma (NHL), including monoclonal antibodies, antisense oligonucleotides, and vaccines.

•  Identify the current treatment standard for aggressive NHL, as well as other drugs now being studied for use.

•  Describe the current and potential future treatment strategies for Hodgkin lymphoma.

•  Understand how differences in response criteria can affect response rates, and how newer imaging techniques such as positron emission tomography scans may help make response criteria more uniform.

•  The American Cancer Society designates this educational activity for a maximum of one-half category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he or she actually spent in the activity.

Each question has ONE best answer.